Atherosclerosis-targeted liposome nanocarrier delivery system and preparation method therefor
US-2024424132-A1 · Dec 26, 2024 · US
US8980919B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-8980919-B2 |
| Application number | US-92241409-A |
| Country | US |
| Kind code | B2 |
| Filing date | Mar 13, 2009 |
| Priority date | Mar 14, 2008 |
| Publication date | Mar 17, 2015 |
| Grant date | Mar 17, 2015 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention relates to a medicament for treating occlusive and/or ischemic vascular disorder comprising a carbostyril derivative and carnitine.
Opening claim text (preview).
The invention claimed is: 1. A method for treating occlusive peripheral arterial disease comprising administering to a patient in need thereof a therapeutically effective amount of a combination comprising as active ingredients 6-[4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxyl]-3,4-dihydrocarbostyril or a salt thereof; and carnitine or a salt thereof; in a ratio of 0.1 to 100 parts by weight of carnitine or a salt thereof per 1 part by weight of the carbostyril derivative or a salt there…
Human Necessities · mapped topic
Human Necessities · mapped topic
Human Necessities · mapped topic
Human Necessities · mapped topic
Human Necessities · mapped topic
Related publications grouped by family.
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Answers are generated from the same data shown on this page.